Oxford Biodynamics PLC
Research Oxford Biodynamics PLC (OBD) on Bullrun: market cap GBX 1.55B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOBD
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyGBX
- Market capGBX 1.55B
- Financial periodFY2025
- RevenueGBP 1.10M
- Revenue growth72.2%
- Net income-GBP 11.15M
- Free cash flow-GBP 7.82M
- Gross margin47.7%
Valuation Snapshot
latest market cap is GBX 1.55B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 1.10M | -GBP 11.15M | -GBP 7.82M | 47.7% | -0.01 | GBP 1.39M | GBP 5.11M | GBP 1.12M |
| FY2024 | GBP 636.00K | -GBP 11.57M | -GBP 10.77M | 45.4% | -0.05 | GBP 1.83M | GBP 5.74M | GBP 4.36M |
| FY2023 | GBP 510.00K | -GBP 10.83M | -GBP 9.01M | 52.2% | -0.07 | GBP 5.25M | GBP 6.44M | GBP 6.06M |
| FY2022 | GBP 154.00K | -GBP 6.71M | -GBP 6.08M | 75.3% | -0.07 | GBP 974.00K | GBP 6.14M | GBP 2.59M |
| FY2021 | GBP 32.15M | -GBP 22.07M | -GBP 13.61M | 50.9% | n/a | GBP 458.00K | GBP 18.70M | GBP 2.92M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-03 | GBX 1.55B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Oxford Biodynamics PLC
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Oxford Biodynamics PLC's market cap?
Oxford Biodynamics PLC's market capitalization is GBX 1.55B.
What does Oxford Biodynamics PLC do?
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker.